Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.

Journal of cutaneous pathology - 1 May 2023

Fayiga Folasade F, Reyes-Hadsall Sophia C, Moreno Brian A, Oh Kei Shing, Brathwaite Carole, Duarte Ana M

Abstract excerpt

Cutaneous non-Langerhans cell histiocytosis (NLCH) is a rare and biologically benign entity that can be broadly classified into two categories: xanthogranuloma and non-xanthogranuloma. The xanthogranuloma family is characterized by a proliferation of histiocytes with both macrophage and dendritic cell differentiation, negative BRAF mutation, and rare Touton-type giant cells. Molecular studies have reported that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Infant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intercellular Signaling Peptides and Proteins

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Receptor, Platelet-Derived Growth Factor beta

Share to Soft Tissue Neoplasms

Share to Xanthomatosis

Source

Identifiers

PMID: 36753059
DOI: 10.1111/cup.14404

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.PMID 36753059Read ↗

Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.Semantic proximity Read ↗

Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.Semantic proximity Read ↗

[Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?]Semantic proximity Read ↗

Erdheim–Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic AdvancesSemantic proximity Read ↗

Molecular and clinicopathologic characterization of pediatric histiocytoses.Semantic proximity Read ↗

Oral Juvenile Xanthogranuloma: A Clinicopathological, Immunohistochemical and BRAF V600E Study of Five New Cases, with Literature Review.Semantic proximity Read ↗

Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinibSemantic proximity Read ↗

Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranulomaSemantic proximity Read ↗

NTRK1 Gene Fusions Are Frequent in Juvenile XanthogranulomaSemantic proximity Read ↗

Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma.Semantic proximity Read ↗

Advances in our understanding of genetic markers and targeted therapies for pediatric LCH.Semantic proximity Read ↗

[An overview of histiocytosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.